2.235SEK+13.34%Mkt Cap: 70.71M SEKP/E: —Last update: 2026-06-01
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testin…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap70.71M SEK
Enterprise Value19.16M SEK
Revenue (TTM)235.00K SEK
Gross Profit-670.00K SEK
Net Income (TTM)-20.56M SEK
Revenue/Share0.0190 SEK
Last Price2.235 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.96
PEG—
EV/EBITDA-1.04
EV/Revenue81.54
P/S265.48
P/B-4.12
EPS (TTM)-2.36
EPS (Forward)-0.18
52W Range
1.20523% of range5.740
52W High5.740 SEK
52W Low1.205 SEK
Profitability
Gross Margin-206.79%
Oper. Margin-27714.28%
EBITDA Margin0.00%
Profit Margin-6345.06%
ROE273.81%
ROA-213.43%
Growth
Revenue Growth-80.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.49M SEK
CapEx (TTM)—
FCF Margin-4798.88%
FCF Yield-15.95%
Net Debt2.08M SEK
Net Debt/EBITDA-0.11
Balance Sheet
Debt/Equity-1.92
Current Ratio2.31
Quick Ratio1.57
Book Value/Sh-0.4790 SEK
Cash/Share0.7660 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:2000
Split DateJul 30, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.31.64M
Float8.66M
Insiders0.00%
Institutions0.00%
Technical
SMA 501.967 (+13.7%)
SMA 2002.276 (-1.8%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)65.37K
Avg Vol (10d)70.10K
Technical Indicators
RSI (14)51.3
MACD0.0161
MACD Signal0.0038
MACD Hist.+0.0123
BB Upper2.082 SEK
BB Middle1.923 SEK
BB Lower1.763 SEK
BB Width16.57%
ATR (14)0.1628 SEK
Vol Ratio (20d)0.67x